These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26576319)

  • 21. The impact of nocturnal disturbances on daily quality of life in patients with Parkinson's disease.
    Yu RL; Tan CH; Wu RM
    Neuropsychiatr Dis Treat; 2015; 11():2005-12. PubMed ID: 26273203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson's Disease: A Pilot Study.
    Zhou H; Li S; Yu H; Sun S; Wan X; Zhu X; Liu CF; Chen L; Xiang W; Sun Y; Chen H; Chen S
    Parkinsons Dis; 2021; 2021():8834950. PubMed ID: 33763199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between severity of motor function and nonmotor symptoms in Parkinson's disease: a post hoc analysis of the RECOVER Study.
    Swick TJ; Friedman JH; Chaudhuri KR; Surmann E; Boroojerdi B; Moran K; Ghys L; Trenkwalder C
    Eur Neurol; 2014; 71(3-4):140-7. PubMed ID: 24457253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients' perception of Parkinson's disease-associated pain following initiation of rotigotine: a multicenter non-interventional study.
    Timmermann L; Oehlwein C; Ransmayr G; Fröhlich H; Will E; Schroeder H; Lauterbach T; Bauer L; Kassubek J
    Postgrad Med; 2017 Jan; 129(1):46-54. PubMed ID: 27883297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rotigotine Objectively Improves Sleep in Parkinson's Disease: An Open-Label Pilot Study with Actigraphic Recording.
    Calandra-Buonaura G; Guaraldi P; Doria A; Zanigni S; Nassetti S; Favoni V; Cevoli S; Provini F; Cortelli P
    Parkinsons Dis; 2016; 2016():3724148. PubMed ID: 26981312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of cutoff scores for the Parkinson's disease sleep scale-2.
    Suzuki K; Miyamoto T; Miyamoto M; Suzuki S; Numao A; Watanabe Y; Tatsumoto M; Sakuta H; Watanabe Y; Fujita H; Iwanami M; Sada T; Kadowaki T; Hashimoto K; Trenkwalder C; Hirata K
    Acta Neurol Scand; 2015 Jun; 131(6):426-30. PubMed ID: 25402773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension study.
    Elmer LW; Surmann E; Boroojerdi B; Jankovic J
    Parkinsonism Relat Disord; 2012 Jun; 18(5):488-93. PubMed ID: 22326237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of gastrointestinal symptoms in Parkinson's disease after a switch from oral therapy to rotigotine transdermal patch: a non-interventional prospective multicenter trial.
    Woitalla D; Kassubek J; Timmermann L; Lauterbach T; Berkels R; Grieger F; Müller T
    Parkinsonism Relat Disord; 2015 Mar; 21(3):199-204. PubMed ID: 25595315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of a once-daily extended-release formulation of pramipexole switched from an immediate-release formulation in patients with advanced Parkinson's disease: results from an open-label study.
    Takanashi M; Shimo Y; Hatano T; Oyama G; Hattori N
    Drug Res (Stuttg); 2013 Dec; 63(12):639-43. PubMed ID: 23884661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Night-time use of rotigotine in advanced Parkinson's disease.
    Canesi M; Mariani CB; Isaias IU; Pezzoli G
    Funct Neurol; 2010; 25(4):201-4. PubMed ID: 21388580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?
    Rosa-Grilo M; Qamar MA; Taddei RN; Pagonabarraga J; Kulisevsky J; Sauerbier A; Chaudhuri KR
    NPJ Parkinsons Dis; 2017; 3():28. PubMed ID: 28890931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease.
    Martinez-Martin P; Rizos AM; Wetmore JB; Antonini A; Odin P; Pal S; Sophia R; Carroll C; Martino D; Falup-Pecurariu C; Kessel B; Andrews T; Paviour D; Trenkwalder C; Chaudhuri KR;
    Mov Disord Clin Pract; 2019 Jan; 6(1):57-64. PubMed ID: 30746417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K; Lyons KE
    Pharmacotherapy; 2009 Dec; 29(12):1452-67. PubMed ID: 19947805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rotigotine transdermal system for the treatment of Parkinson's disease.
    Pham DQ; Nogid A
    Clin Ther; 2008 May; 30(5):813-24. PubMed ID: 18555929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rotigotine Transdermal Patch: A Review in Parkinson's Disease.
    Frampton JE
    CNS Drugs; 2019 Jul; 33(7):707-718. PubMed ID: 31243728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study.
    Oertel W; Trenkwalder C; Beneš H; Ferini-Strambi L; Högl B; Poewe W; Stiasny-Kolster K; Fichtner A; Schollmayer E; Kohnen R; García-Borreguero D;
    Lancet Neurol; 2011 Aug; 10(8):710-20. PubMed ID: 21705273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson's disease.
    Chung SJ; Asgharnejad M; Bauer L; Ramirez F; Jeon B
    Expert Opin Pharmacother; 2016 Aug; 17(11):1453-61. PubMed ID: 27322571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson's disease.
    Choi JH; Kim HJ; Lee JY; Yoo D; Im JH; Paek SH; Jeon B
    PLoS One; 2019; 14(8):e0221219. PubMed ID: 31454366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study.
    Zhang ZX; Shang HF; Hu X; Chen S; Zhao Z; Du X; Surmann E; Bauer L; Asgharnejad M
    Parkinsonism Relat Disord; 2016 Jul; 28():49-55. PubMed ID: 27172830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
    Bogan RK
    Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.